Parkinson's Blog

0 Announces First Project Within Multi-Year Collaboration Agreement with The Michael J. Fox Foundation (MJFF) to Generate Human Cell Products for Research and Drug Discovery in Parkinson’s disease

CAMBRIDGE, England, March 05, 2024–, the company coding human cells for novel cures, today announces the first project within a multi-year collaboration agreement with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to prioritise the development and delivery of a range of human cell products relevant to Parkinson’s disease (PD).